Stock Events

Stock Events

Achieve Life Sciences 

$5.38
77
-$0.14-2.54% Today

Statistics

Day High
5.75
Day Low
5.32
52W High
6.16
52W Low
2
Volume
1,185,359
Avg. Volume
1,415,223
Mkt Cap
286.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.38
-0.31
-0.23
-0.16
Expected EPS
-0.157111
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-79.65MNet Income

Analyst Ratings

12.50Average Price Target
The highest estimate is 13.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACHV. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is involved in developing treatments in various therapeutic areas, including smoking cessation aids which compete with Achieve Life Sciences' cytisinicline product.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline produces Nicorette, a nicotine replacement therapy, directly competing with Achieve's smoking cessation products.
Altria Group
MO
Mkt Cap120.13B
Altria Group, through its investments in nicotine replacement and cessation products, competes in the same market as Achieve Life Sciences.
British American Tobacco
BTI
Mkt Cap134.67B
British American Tobacco, with its investments in smoking cessation tools and nicotine replacement therapies, competes with Achieve Life Sciences.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its subsidiary producing Nicorette, competes in the nicotine replacement therapy market.
Novartis
NVS
Mkt Cap292.07B
Novartis offers smoking cessation products, which places it in direct competition with Achieve Life Sciences.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. competes through its research and development in therapies that could potentially include smoking cessation aids.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, with its broad interest in healthcare solutions, could potentially compete in the smoking cessation aid market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries competes in the generic drug market, including potential production of smoking cessation aids.
22nd Century Group
XXII
Mkt Cap2.26M
22nd Century Group, Inc. specializes in tobacco products with reduced nicotine levels, indirectly competing with smoking cessation aids.

About

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
Show more...
CEO
Mr. Erik Atkisson
Employees
25
Country
United States
ISIN
US0044685008

Listings

XNAS
US
ACHV
STU
DE
SP4P.STU
F
DE
SP4P.F
MU
DE
SP4P.MU

0 Comments

Share your thoughts

FAQ

What is Achieve Life Sciences stock price today?▼
The current price of ACHV is $5.38 USD — it has decreased by -2.54% in the past 24 hours. Watch Achieve Life Sciences stock price performance more closely on the chart.
What is Achieve Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Achieve Life Sciences stocks are traded under the ticker ACHV.
Is Achieve Life Sciences stock price growing?▼
ACHV stock has fallen by -1.09% compared to the previous week, the month change is a +2.46% rise, over the last year Achieve Life Sciences has showed a +66.77% increase.
What is Achieve Life Sciences market cap?▼
Today Achieve Life Sciences has the market capitalization of 286.4M
When is the next Achieve Life Sciences earnings date?▼
Achieve Life Sciences is going to release the next earnings report on August 06, 2026.
What were Achieve Life Sciences earnings last quarter?▼
ACHV earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.3 USD resulting in a +36.36% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Achieve Life Sciences revenue for the last year?▼
Achieve Life Sciences revenue for the last year amounts to 0 USD.
What is Achieve Life Sciences net income for the last year?▼
ACHV net income for the last year is -79.65M USD.
How many employees does Achieve Life Sciences have?▼
As of June 15, 2026, the company has 25 employees.
In which sector is Achieve Life Sciences located?▼
Achieve Life Sciences operates in the Health & Wellness sector.
When did Achieve Life Sciences complete a stock split?▼
The last stock split for Achieve Life Sciences was on July 31, 2020 with a ratio of 1:20.
Where is Achieve Life Sciences headquartered?▼
Achieve Life Sciences is headquartered in Bothell, United States.